










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>Follitropin - Revision history</title>
		<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;action=history</link>
		<description>Revision history for this page on the wiki</description>
		<language>en</language>
		<generator>MediaWiki 1.11.2</generator>
		<lastBuildDate>Tue, 07 Apr 2026 06:52:40 GMT</lastBuildDate>
		<item>
			<title>Jaime Prilusky: Follistin moved to Follitropin: requested by Editor</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2991313&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;a href=&quot;/wiki/index.php/Follistin&quot; title=&quot;Follistin&quot;&gt;Follistin&lt;/a&gt; moved to &lt;a href=&quot;/wiki/index.php/Follitropin&quot; title=&quot;Follitropin&quot;&gt;Follitropin&lt;/a&gt;: requested by Editor&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 16:32, 13 January 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;</description>
			<pubDate>Sun, 13 Jan 2019 16:32:58 GMT</pubDate>			<dc:creator>Jaime Prilusky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Michal Harel at 11:35, 13 January 2019</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2991285&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:35, 13 January 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''Follitropin β''' injection is used to treat infertility in both males and females. Brand names for follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;include Follistim, Follistim AQ, and Gonal-F RFF. This hormone is man-made gonadotropin to replace a bodily hormone called Follicle Stimulating Hormone (FSH). In males, FSH controls the production of sperm and in females FSH controls the maturation of follicles and ultimately their ability to ovulate. FSH is produced by the pituitary gland after receiving a signal from the hypothalamus. Some fertility programs such as Assisted Reproductive Technology (ART) use follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta&lt;/del&gt;, in conjunction with human chorionic gonadotropin (hCG), to help oocytes develop in women. Follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;is also used in men, along with hCG to increase sperm count.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''Follitropin β''' injection is used to treat infertility in both males and females. Brand names for follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;include Follistim, Follistim AQ, and Gonal-F RFF. This hormone is man-made gonadotropin to replace a bodily hormone called Follicle Stimulating Hormone (FSH). In males, FSH controls the production of sperm and in females FSH controls the maturation of follicles and ultimately their ability to ovulate. FSH is produced by the pituitary gland after receiving a signal from the hypothalamus. Some fertility programs such as Assisted Reproductive Technology (ART) use follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β&lt;/ins&gt;, in conjunction with human chorionic gonadotropin (hCG), to help oocytes develop in women. Follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;is also used in men, along with hCG to increase sperm count.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function and Clinical Use &amp;lt;ref&amp;gt;Drug Approval Package: Follistim AQ (Follitropin) NDA #021273. (n.d.). Retrieved April 18, 2017, from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021273s000TOC.cfm&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function and Clinical Use &amp;lt;ref&amp;gt;Drug Approval Package: Follistim AQ (Follitropin) NDA #021273. (n.d.). Retrieved April 18, 2017, from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021273s000TOC.cfm&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;FSH stimulates the growth and healthy function of ovarian follicles. FSH in males is involved in maintaining normal levels of sperm production &amp;lt;ref name=&amp;quot;Hillier&amp;quot;&amp;gt;Hillier, S. G. (1994). &amp;quot;Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Human Reproduction&amp;quot;, 9(2), 188–191. [https://doi.org/10.1093/oxfordjournals.humrep.a138480]&amp;lt;/ref&amp;gt;. The first step of follicle formation is determined by the concentration of FSH. A woman who is not producing enough FSH will not be able to meet the concentration threshold necessary to begin pre-ovulatory development. If pre-ovulatory development does not occur a mature egg will not be formed to be fertilized. In females, FSH is critical for the onset of follicular development and the number of follicles reaching maturity. Follistim is used to treat these infertility issues. Human chorionic gonadotropin (hCG) must be given after follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;injections in order for ovulation to take place after follicular growth. Follistim is intended for use in women who are participating in Assisted Reproductive Technology (ART) in order for multiple follicular development. It is also used in women who are unable to ovulate due to functional issues and not failure of the ovary itself. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;FSH stimulates the growth and healthy function of ovarian follicles. FSH in males is involved in maintaining normal levels of sperm production &amp;lt;ref name=&amp;quot;Hillier&amp;quot;&amp;gt;Hillier, S. G. (1994). &amp;quot;Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Human Reproduction&amp;quot;, 9(2), 188–191. [https://doi.org/10.1093/oxfordjournals.humrep.a138480]&amp;lt;/ref&amp;gt;. The first step of follicle formation is determined by the concentration of FSH. A woman who is not producing enough FSH will not be able to meet the concentration threshold necessary to begin pre-ovulatory development. If pre-ovulatory development does not occur a mature egg will not be formed to be fertilized. In females, FSH is critical for the onset of follicular development and the number of follicles reaching maturity. Follistim is used to treat these infertility issues. Human chorionic gonadotropin (hCG) must be given after follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;injections in order for ovulation to take place after follicular growth. Follistim is intended for use in women who are participating in Assisted Reproductive Technology (ART) in order for multiple follicular development. It is also used in women who are unable to ovulate due to functional issues and not failure of the ovary itself. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Side Effects &amp;lt;ref&amp;gt;Follistim AQ Side Effects in Detail. (n.d.). Retrieved April 18, 2017, from https://www.drugs.com/sfx/follistim-aq-side-effects.html&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Side Effects &amp;lt;ref&amp;gt;Follistim AQ Side Effects in Detail. (n.d.). Retrieved April 18, 2017, from https://www.drugs.com/sfx/follistim-aq-side-effects.html&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Possible side effects from this drug include abnormal ovarian enlargement, Ovarian Hyperstimulation Syndrome (OHSS), spontaneous abortion, severe abdominal/stomach pain, bloating and rapid weight gain, nausea, and vomiting.  Less common side effects include heavy non-menstrual vaginal bleeding, unusual tiredness and/or weakness, increased heart rate, and swelling of the breasts &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Possible side effects from this drug include abnormal ovarian enlargement, Ovarian Hyperstimulation Syndrome (OHSS), spontaneous abortion, severe abdominal/stomach pain, bloating and rapid weight gain, nausea, and vomiting.  Less common side effects include heavy non-menstrual vaginal bleeding, unusual tiredness and/or weakness, increased heart rate, and swelling of the breasts &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structure &amp;lt;ref&amp;gt;DrugBank (Ed.). (2017, April 17). Follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta&lt;/del&gt;. In DrugBank. Retrieved from https://www.drugbank.ca/drugs/DB00066&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structure &amp;lt;ref&amp;gt;DrugBank (Ed.). (2017, April 17). Follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β&lt;/ins&gt;. In DrugBank. Retrieved from https://www.drugbank.ca/drugs/DB00066&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;contains 2 glycoprotein subunits – &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;alpha&lt;/del&gt;, consisting of 92 amino acids, and &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta&lt;/del&gt;, consisting of 111 amino acids. The &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;alpha &lt;/del&gt;subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;contains 2 glycoprotein subunits – &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;α&lt;/ins&gt;, consisting of 92 amino acids, and &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β&lt;/ins&gt;, consisting of 111 amino acids. The &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;α &lt;/ins&gt;subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Beta &lt;/del&gt;is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyr335/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;  that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyr335/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;  that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/StructureSection&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==3D structures of follitropin==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==3D structures of follitropin==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[4ay9]], [[4mqw]], [[1xwd]] – hFTR &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;b &lt;/del&gt;+ FTR receptor + glycoprotein hormone – human&amp;lt;br /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[4ay9]], [[4mqw]], [[1xwd]] – hFTR &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β &lt;/ins&gt;+ FTR receptor + glycoprotein hormone – human&amp;lt;br /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Sun, 13 Jan 2019 11:35:18 GMT</pubDate>			<dc:creator>Michal Harel</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Michal Harel at 11:26, 13 January 2019</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2991282&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:26, 13 January 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 15:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 15:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyr335/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;  that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyr335/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;  that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==3D structures of follitropin==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[4ay9]], [[4mqw]], [[1xwd]] – hFTR b + FTR receptor + glycoprotein hormone – human&amp;lt;br /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Sun, 13 Jan 2019 11:26:46 GMT</pubDate>			<dc:creator>Michal Harel</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Michal Harel at 11:17, 13 January 2019</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2991280&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:17, 13 January 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Background &amp;lt;ref&amp;gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Background &amp;lt;ref&amp;gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='4mqw' size='400' frame='true' align='right' side='right' caption='Glycosylated human follitropin subunit β (red) complex with follitropin receptor (dark red) &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;and &lt;/del&gt;glycoprotein hormone (gold) (PDB code [[4mqw]])'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='4mqw' size='400' frame='true' align='right' side='right' caption='Glycosylated human follitropin subunit β (red) complex with follitropin receptor (dark red)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;glycoprotein hormone (gold)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, ethylene glycol and jeffamine &lt;/ins&gt;(PDB code [[4mqw]])'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Sun, 13 Jan 2019 11:17:25 GMT</pubDate>			<dc:creator>Michal Harel</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Michal Harel at 11:15, 13 January 2019</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2991279&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:15, 13 January 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Background &amp;lt;ref&amp;gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Background &amp;lt;ref&amp;gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='4mqw' size='400' frame='true' align='right' side='right' caption='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Human &lt;/del&gt;follitropin subunit β (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;green&lt;/del&gt;) complex with follitropin receptor and glycoprotein hormone (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;grey&lt;/del&gt;) (PDB code [[4mqw]])'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='4mqw' size='400' frame='true' align='right' side='right' caption='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Glycosylated human &lt;/ins&gt;follitropin subunit β (&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;red&lt;/ins&gt;) complex with follitropin receptor &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(dark red) &lt;/ins&gt;and glycoprotein hormone (&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;gold&lt;/ins&gt;) (PDB code [[4mqw]])'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Sun, 13 Jan 2019 11:15:40 GMT</pubDate>			<dc:creator>Michal Harel</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Michal Harel at 11:11, 13 January 2019</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2991278&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:11, 13 January 2019&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Background &amp;lt;ref&amp;gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Background &amp;lt;ref&amp;gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='4mqw' size='400' frame='true' align='right' side='right' caption='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;hFSH~Receptor&lt;/del&gt;'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='4mqw' size='400' frame='true' align='right' side='right' caption='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Human follitropin subunit β (green) complex with follitropin receptor and glycoprotein hormone (grey) (PDB code [[4mqw]])&lt;/ins&gt;'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follitropin &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;beta &lt;/del&gt;injection is used to treat infertility in both males and females. Brand names for follitropin beta include Follistim, Follistim AQ, and Gonal-F RFF. This hormone is man-made gonadotropin to replace a bodily hormone called Follicle Stimulating Hormone (FSH). In males, FSH controls the production of sperm and in females FSH controls the maturation of follicles and ultimately their ability to ovulate. FSH is produced by the pituitary gland after receiving a signal from the hypothalamus. Some fertility programs such as Assisted Reproductive Technology (ART) use follitropin beta, in conjunction with human chorionic gonadotropin (hCG), to help oocytes develop in women. Follitropin beta is also used in men, along with hCG to increase sperm count.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/ins&gt;Follitropin &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;β''' &lt;/ins&gt;injection is used to treat infertility in both males and females. Brand names for follitropin beta include Follistim, Follistim AQ, and Gonal-F RFF. This hormone is man-made gonadotropin to replace a bodily hormone called Follicle Stimulating Hormone (FSH). In males, FSH controls the production of sperm and in females FSH controls the maturation of follicles and ultimately their ability to ovulate. FSH is produced by the pituitary gland after receiving a signal from the hypothalamus. Some fertility programs such as Assisted Reproductive Technology (ART) use follitropin beta, in conjunction with human chorionic gonadotropin (hCG), to help oocytes develop in women. Follitropin beta is also used in men, along with hCG to increase sperm count.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Sun, 13 Jan 2019 11:11:50 GMT</pubDate>			<dc:creator>Michal Harel</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Brandon Chocklett at 00:37, 20 April 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2742723&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:37, 20 April 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt; Follitropin Beta (By injection) - National Library of Medicine - PubMed Health. Retrieved March 28, 2017, from   https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010381/?report=details&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follistim® AQ Cartridge [physician insert]. Food and Drug Administration. Retrieved March 26, 2017,  from https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021273lbl.pdf &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;DrugBank (Ed.).  Follitropin beta. In DrugBank. Retrieved March 27, 2017,  from https://www.drugbank.ca/drugs/DB00066&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;http://www.rcsb.org/pdb/explore/literature.do?structureId=1XWD - THE ONLY ONE THAT NEEDS TO BE DONE&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;https://www.drugbank.ca/drugs/DB00066&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;http://www.merck.com/product/usa/pi_circulars/f/follistim_aq_cartridge/follistim_cartridge_pi.pdf&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;https://www.drugs.com/sfx/follistim-aq-side-effects.html&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Hillier, S. G. (1994). &amp;quot;Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Human Reproduction&amp;quot;, 9(2), 188–191. [https://doi.org/10.1093/oxfordjournals.humrep.a138480]&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;DrugBank (Ed.). (2017, April 17). Follitropin beta. In DrugBank. Retrieved from https://www.drugbank.ca/drugs/DB00066&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Drug Approval Package: Follistim AQ (Follitropin) NDA #021273. (n.d.). Retrieved April 18, 2017, from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021273s000TOC.cfm&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follistim AQ Side Effects in Detail. (n.d.). Retrieved April 18, 2017, from https://www.drugs.com/sfx/follistim-aq-side-effects.html&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;FOLLISTIM® AQ Cartridge. (n.d.). Retrieved April 18, 2017, from https://www.merckconnect.com/follistimaq/overview.html?hcpUser=yes&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;pmhdev. (2017). Follitropin Beta (Subcutaneous route). PubMed Health. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0045885/ - by injection reference&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 20 Apr 2017 00:37:47 GMT</pubDate>			<dc:creator>Brandon Chocklett</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Angelina Smeragulioulo at 00:37, 20 April 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2742722&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:37, 20 April 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin beta are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin beta is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin beta contains 2 glycoprotein subunits – alpha, consisting of 92 amino acids, and beta, consisting of 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the beta subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin beta are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin beta is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin beta contains 2 glycoprotein subunits – alpha, consisting of 92 amino acids, and beta, consisting of 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the beta subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;There are several pathways Follitropin Beta can take in order for signal transduction to occur. &lt;/del&gt;Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyr335/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;  that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyr335/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;  that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 20 Apr 2017 00:37:38 GMT</pubDate>			<dc:creator>Angelina Smeragulioulo</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Angelina Smeragulioulo at 00:36, 20 April 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2742721&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:36, 20 April 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin beta are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin beta is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin beta contains 2 glycoprotein subunits – alpha, consisting of 92 amino acids, and beta, consisting of 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the beta subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin beta are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin beta is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin beta contains 2 glycoprotein subunits – alpha, consisting of 92 amino acids, and beta, consisting of 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the beta subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;There are several pathways Follitropin Beta can take in order for signal transduction to occur. Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Tyrosine&lt;/del&gt;/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;into &lt;/del&gt;that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;There are several pathways Follitropin Beta can take in order for signal transduction to occur. Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Tyr335&lt;/ins&gt;/1'&amp;gt;(Sulfotyrosine Residue)&amp;lt;/scene&amp;gt; &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt; &lt;/ins&gt;that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 20 Apr 2017 00:36:57 GMT</pubDate>			<dc:creator>Angelina Smeragulioulo</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
		<item>
			<title>Angelina Smeragulioulo at 00:32, 20 April 2017</title>
			<link>http://52.214.119.220/wiki/index.php?title=Follitropin&amp;diff=2742716&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 00:32, 20 April 2017&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 13:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin beta are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin beta is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin beta contains 2 glycoprotein subunits – alpha, consisting of 92 amino acids, and beta, consisting of 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the beta subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The amino acid sequence and structure of follitropin beta are exactly the same as that of human urinary follicle-stimulating hormone (hFSH). Follitropin beta is a glycoprotein hormone that is created through recombinant DNA technology. The dimeric structure of follitropin beta contains 2 glycoprotein subunits – alpha, consisting of 92 amino acids, and beta, consisting of 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 &amp;lt;scene name='75/758465/Alpha_glycosylation/1'&amp;gt;(Glycosylated Alpha Subunit)&amp;lt;/scene&amp;gt; the beta subunit is glycosylated at Asn 7 and Asn 24. &amp;lt;scene name='75/758465/Beta_subunit_glycosylation_sit/1'&amp;gt;(Glycosylated Beta Subunit)&amp;lt;/scene&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Mechanism &amp;lt;ref&amp;gt;Telikicherla, D., Ambekar, A., Palapetta, S. M., Dwivedi, S. B., Raju, R., Sharma, J., … Pandey, A. (2011). A comprehensive curated resource for follicle stimulating hormone signaling. BMC Research Notes, 4, 408. https://doi.org/10.1186/1756-0500-4-408&amp;lt;/ref&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;There are several pathways Follitropin Beta can take in order for signal transduction to occur. Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyrosine/1'&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;TextToBeDisplayed&lt;/del&gt;&amp;lt;/scene&amp;gt;into that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;There are several pathways Follitropin Beta can take in order for signal transduction to occur. Follitropin Beta is a form of follicular stimulating hormone (FSH), which acts through a transmembrane G-protein receptor on the surface of granulosa cells of the ovaries and sertoli cells of the testis. FSH first undergoes a conformational change that forms a new pocket on its surface.  Its receptor, FSHR, then inserts a sulfotyrosine residue &amp;lt;scene name='75/758465/Tyrosine/1'&amp;gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(Sulfotyrosine Residue)&lt;/ins&gt;&amp;lt;/scene&amp;gt;into that pocket to bind FSH, and with FSH bound the transmembrane receptor undergoes a conformational change. The conformational change by the receptor mechanically activates the G-protein, which detaches from the receptor and activates the second messenger adenylyl cyclase. Adenylyl cyclase leads to the increased production of cAMP that in turn activates a protein kinase cascade through protein kinase A. One protein kinase cascade that could be activated is the PI3K (phosphoinositide-3-kinase)/AKT pathway, which leads to the growth and maturation of germ cells.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 20 Apr 2017 00:32:39 GMT</pubDate>			<dc:creator>Angelina Smeragulioulo</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:Follitropin</comments>		</item>
	</channel>
</rss>